Thus, one mean of evaluating these preferences and bringing them into accord is to take the required perspective for the situation. ![]() However, several studies have found a divergence in patients’ and physicians’ preferences or priorities regarding prevention and therapy (e.g. Therefore, while it is now important to measure the benefits and to prioritize the needs of patients, it will be even more so in the future. But also, other countries are interested in reliable methods to measure benefits for patients, for example, to support Health Technology Assessments by patient preferences. In this context, patient-relevant outcomes have drawn greater attention because the added benefit for patients determines the reimbursement price. the Act on the Reform of the Market for Medicinal Products in 2011 (in German: AMNOG ). German politicians have adopted new laws to manage the costs of pharmaceuticals, e.g. Furthermore, innovations in medical care, such as equipment, pharmaceuticals, and treatment methods, are also driving up costs. ![]() Exacerbating this issue is the problem that many developed countries face, that is, the rising proportion of older, multimorbid patients, who serve to raise the cost of health care. The resources in health care systems are limited.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |